317 results
Page 14 of 16
8-K
EX-99.1
2gskd 44hvseww2awkfb
23 Dec 10
Regulation FD Disclosure
12:00am
8-K
f7dra3fttb
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
jnup30a
4 Nov 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
byalvuh
18 Oct 10
Alimera Sciences Secures $32.5 Million Credit Facility
12:00am
8-K
EX-10.1
j47bxh
18 Oct 10
Alimera Sciences Secures $32.5 Million Credit Facility
12:00am
8-K
EX-10.2
b55sm5v2fita5
18 Oct 10
Alimera Sciences Secures $32.5 Million Credit Facility
12:00am
8-K
EX-99.1
0ocq3
30 Aug 10
Alimera Sciences’ Iluvien® Receives Fda Priority Review for the Treatment of Diabetic Macular Edema
12:00am
8-K
EX-99.1
3eeplyyt m5ehuccwykz
12 Aug 10
Results of Operations and Financial Condition
12:00am
8-K
ciqcmglhtvm5
12 Aug 10
Results of Operations and Financial Condition
12:00am
10-Q
ln1blgow32n
7 Jun 10
Quarterly report
12:00am
8-K
EX-99.1
lh0 we2ak1sqanxmw9xv
3 Jun 10
Results of Operations and Financial Condition
12:00am
8-K
xk1guzq4fgfvc
3 Jun 10
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
3yy5j
27 May 10
Alimera Announces Iluvien® Post 24-MONTH Visual Acuity Data Indicates Significant Long-term Improvement In Dme
12:00am
8-K
8xbazw
27 May 10
Alimera Announces Iluvien® Post 24-MONTH Visual Acuity Data Indicates Significant Long-term Improvement In Dme
12:00am
424B4
nil pob2hrmgtd2xo8wt
23 Apr 10
Prospectus supplement with pricing info
12:00am